Literature DB >> 22717190

Social networks and HCV viraemia in anti-HCV-positive rural drug users.

A M Young1, A B Jonas2, J R Havens2.   

Abstract

Although social networks are known to play an important role in drug-using behaviours associated with hepatitis C virus (HCV) infection, literature on social networks and HCV is inconsistent. This exploratory study examined HCV RNA distribution within a social network of anti-HCV-positive non-medical prescription opioid users (NMPOUs) in rural Appalachia. Participants were tested serologically for HCV RNA, and behavioural, demographic, and network data were collected using interview-administered questionnaires. Multivariate analyses were performed using logistic regression. Behavioural and demographic characteristics did not differ by RNA status. In the multivariate model, recent injecting drug users (IDUs) were more likely to be RNA positive [odds ratio (OR) 4·06, 95% confidence interval (CI) 1·04-15·83], and turnover into an IDU's drug network was significantly protective (OR 0·15, 95% CI 0·03-0·75). This is the first study to date to examine HCV distribution in rural NMPOUs from a network perspective and demonstrates that network characteristics significantly contribute to the epidemiology of HCV in this understudied, high-risk population.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22717190      PMCID: PMC3469752          DOI: 10.1017/S0950268812000696

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  32 in total

1.  Sociometric risk networks and risk for HIV infection.

Authors:  S R Friedman; A Neaigus; B Jose; R Curtis; M Goldstein; G Ildefonso; R B Rothenberg; D C Des Jarlais
Journal:  Am J Public Health       Date:  1997-08       Impact factor: 9.308

2.  Transitions to injecting drug use among noninjecting heroin users: social network influence and individual susceptibility.

Authors:  Alan Neaigus; V Anna Gyarmathy; Maureen Miller; Veronica M Frajzyngier; Samuel R Friedman; Don C Des Jarlais
Journal:  J Acquir Immune Defic Syndr       Date:  2006-04-01       Impact factor: 3.731

3.  Determinants of injection drug user (IDU) syringe sharing: the relationship between availability of syringes and risk network member characteristics in Winnipeg, Canada.

Authors:  Souradet Y Shaw; Lena Shah; Ann M Jolly; John L Wylie
Journal:  Addiction       Date:  2007-10       Impact factor: 6.526

4.  Transition from first illicit drug use to first injection drug use among rural Appalachian drug users: a cross-sectional comparison and retrospective survival analysis.

Authors:  April M Young; Jennifer R Havens
Journal:  Addiction       Date:  2011-10-26       Impact factor: 6.526

5.  Potential risk factors for the transition to injecting among non-injecting heroin users: a comparison of former injectors and never injectors.

Authors:  A Neaigus; M Miller; S R Friedman; D L Hagen; S J Sifaneck; G Ildefonso; D C des Jarlais
Journal:  Addiction       Date:  2001-06       Impact factor: 6.526

6.  A randomized intervention trial to reduce the lending of used injection equipment among injection drug users infected with hepatitis C.

Authors:  Mary H Latka; Holly Hagan; Farzana Kapadia; Elizabeth T Golub; Sebastian Bonner; Jennifer V Campbell; Micaela H Coady; Richard S Garfein; Minya Pu; Dave L Thomas; Thelma K Thiel; Steffanie A Strathdee
Journal:  Am J Public Health       Date:  2008-04-01       Impact factor: 9.308

7.  Norms, social networks, and HIV-related risk behaviors among urban disadvantaged drug users.

Authors:  Carl A Latkin; Valerie Forman; Amy Knowlton; Susan Sherman
Journal:  Soc Sci Med       Date:  2003-02       Impact factor: 4.634

8.  Risk factors for the transition from noninjection to injection drug use and accompanying AIDS risk behavior in a cohort of drug users.

Authors:  E J van Ameijden; J A van den Hoek; C Hartgers; R A Coutinho
Journal:  Am J Epidemiol       Date:  1994-06-15       Impact factor: 4.897

9.  Hepatitis C virus infection among drug injectors in St Petersburg, Russia: social and molecular epidemiology of an endemic infection.

Authors:  Elijah Paintsil; Sergei V Verevochkin; Elena Dukhovlinova; Linda Niccolai; Russell Barbour; Edward White; Olga V Toussova; Louis Alexander; Andrei P Kozlov; Robert Heimer
Journal:  Addiction       Date:  2009-08-27       Impact factor: 6.526

10.  Molecular epidemiology of hepatitis C virus in a social network of injection drug users.

Authors:  Campbell K Aitken; Rhonda F McCaw; D Scott Bowden; Samantha L Tracy; Jenny G Kelsall; Peter G Higgs; Michael J Kerger; Hoang Nguyen; J Nick Crofts
Journal:  J Infect Dis       Date:  2004-09-23       Impact factor: 5.226

View more
  7 in total

1.  Rural risk environments for hepatitis c among young adults in appalachian kentucky.

Authors:  David H Cloud; Umedjon Ibragimov; Nadya Prood; April M Young; Hannah L F Cooper
Journal:  Int J Drug Policy       Date:  2019-05-18

2.  Social norms associated with nonmedical opioid use in rural communities: a systematic review.

Authors:  Rebecca Bolinski; Kaitlin Ellis; Whitney E Zahnd; Suzan Walters; Colleen McLuckie; John Schneider; Christofer Rodriguez; Jerel Ezell; Samuel R Friedman; Mai Pho; Wiley D Jenkins
Journal:  Transl Behav Med       Date:  2019-11-25       Impact factor: 3.046

Review 3.  Injection drug use, HIV/HCV, and related services in nonurban areas of the United States: A systematic review.

Authors:  Catherine E Paquette; Robin A Pollini
Journal:  Drug Alcohol Depend       Date:  2018-05-08       Impact factor: 4.492

4.  Healthcare contact and treatment uptake following hepatitis C virus screening and counseling among rural Appalachian people who use drugs.

Authors:  Dustin B Stephens; April M Young; Jennifer R Havens
Journal:  Int J Drug Policy       Date:  2017-06-23

Review 5.  Network-Based Research on Rural Opioid Use: an Overview of Methods and Lessons Learned.

Authors:  April M Young; Abby E Rudolph; Jennifer R Havens
Journal:  Curr HIV/AIDS Rep       Date:  2018-04       Impact factor: 5.071

Review 6.  HIV/HCV Co-infection: Burden of Disease and Care Strategies in Appalachia.

Authors:  Jonathan P Moorman; Matthew R Krolikowski; Stephanie M Mathis; Robert P Pack
Journal:  Curr HIV/AIDS Rep       Date:  2018-08       Impact factor: 5.071

7.  Injection drug network characteristics as a predictor of injection behaviour.

Authors:  Tim Spelman; Rachel Sacks-Davis; Paul Dietze; Peter Higgs; Margaret Hellard
Journal:  Epidemiol Infect       Date:  2019-01       Impact factor: 2.451

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.